Physician profile
Martina J Krone
NPI 1609654284
$951.41
in general payments reported to CMS, 2019-2025
18 companies · $327 in 2025
The $327 reported for 2025 was more than what 77% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.99 · 2024: $605 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $164.11 | 2024-2025 | Sublocade |
| Corcept Therapeutics | $134.27 | 2023-2025 | Korlym |
| Braeburn INC. | $120.48 | 2024-2025 | Brixadi |
| Glaxosmithkline, LLC. | $98.71 | 2024 | Arexvy |
| Lilly USA, LLC | $62.14 | 2024-2025 | Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $56.65 | 2024 | Recorlev, Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $53.68 | 2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Recordati_rare_diseases_inc. | $39.90 | 2025 | Isturisa |
| Abbvie INC. | $32.25 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $30.84 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.49 | 2025 | |
| Mannkind Corporation | $22.78 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $22.09 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.89 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.54 | 2024 | Farxiga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $16.97 | 2024 | Uzedy |
| Phathom Pharmaceuticals, INC. | $16.45 | 2024 | Voquezna |
| Novo Nordisk INC | $13.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martina Krone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.